{
    "nct_id": "NCT04857697",
    "official_title": "Engineering Gut Microbiome to Target Cancer-Immune Microenvironment in Breast and Lung Cancer",
    "inclusion_criteria": "* >= 18 years of age\n* Histologically confirmed adenocarcinoma of the breast operable stage I-III or histologically confirmed carcinoma of the lung operable stage I-III will be enrolled prior to their definitive surgery\n* Patients must have adequate organ function\n* Patients must be willing to provide tissue, blood and stool samples for the research study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients must not receive systemic neoadjuvant therapy\n* Patients must not have taken any probiotics in the past 30 days prior to the enrollment\n* Patients with autoimmune disease, immune deficiency such as human immunodeficiency virus (HIV), irritable bowel, known diverticulosis, and other serious gastrointestinal (GI) conditions at treating physician's discretion will be excluded",
    "miscellaneous_criteria": ""
}